🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 76029N106
- Market Cap
- Mid Cap
- IPO
- 7/20/2018 · $15.00/share
Business: Replimune Group, Inc. is a clinical-stage biotechnology company committed to applying our leading expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients. The Company uses its proprietary Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors.
Company Contact
- CEO
- Sushil Patel
- CFO
- Emily Hill
- Headquarters
- 500 Unicorn Park, Woburn MA 01801
- Phone
- 403-777-2500 · Toll-Free 888-770-2633
- Investor Relations
- Chris Brinzey, WestWicke Partners · 888-770-2633 · chris.brinzey@westwicke.com